FONAR Reports 33% Increase in Net Income to $1.8 Million for 2nd Quarter of Fiscal Year 2012

FONAR Corporation (NASDAQ: FONR - News), The Inventor of MR Scanning™, reported today its financial results for the second quarter of fiscal year 2012. For the three months ended December 31, 2011, net income increased 33% to $1.8 million, income from operations increased 31% to $1.9 million while total revenues increased 16% to $9.3 million, as compared to the corresponding fiscal quarter one year earlier.

Results from the Second Quarter Fiscal 2012 Financial Statement:

The basic income per common share increased 56% to $0.50 for the six months ended December 31, 2011 as compared to $0.32 for the same period one year earlier. For the quarter ended December 31, 2011 and 2010, the basic net income per common share was $0.25.

Published: 14 February 2012
Written by Editor
Nasdaq   Healthcare   Financial Results   Up on News   Interesting News  
Read more: FONAR Corporation ( FONR )

Hansen Medical to Showcase Magellan(TM) Robotic System at Leipzig Interventional Course

Hansen Medical, Inc. (NASDAQ: HNSN - News), a global leader in flexible robotics and the developer of robotic technology for accurate 3D control of catheter movement, today announced it will showcase its Magellan™ Robotic System at the Leipzig Interventional Course (LINC), from January 25-28, at the Trade Fair Leipzig, Hall 4, in Leipzig, Germany.

Hansen Medical will also be exhibiting its NorthStar™ Robotic Catheter, designed to work with the Magellan Robotic System. The NorthStar Catheter is designed to simplify and enhance catheter navigation and therapeutic intervention through a variety of clinical cases in the peripheral vasculature. The Magellan Robotic System and NorthStar Robotic Catheter are CE marked and available for sale in Europe.

Published: 19 January 2012
Written by Editor
Nasdaq   Healthcare   Project Updates   Up on News   Interesting News  
Read more: Hansen Medical Inc ( HNSN )

Delcath Appoints Gregory Gores, M.D. to Medical Advisory Board

Delcath Systems, Inc. (NASDAQ: DCTH - News) appointed Gregory Gores , M.D. to the Company's Medical Advisory Board.

"As a widely respected hepatologist and 2011 President of the International Liver Cancer Association (ILCA), Dr. Gores will contribute a wealth of clinical knowledge on hepatotoxicity and drug induced liver pathology to our Medical Advisory Board," said Eamonn P. Hobbs , CEO & President of Delcath Systems.  "His insight will help provide valuable support to the commercialization of the Delcath Hepatic CHEMOSAT® Delivery System in Europe and the rest of the world, as well as to our regulatory process in the United States ."

Published: 21 December 2011
Written by Editor
Nasdaq   Healthcare   Up on News   Interesting News  
Read more: Delcath Systems Inc ( DCTH )

Luna Innovations Sets New Strategy for Future

Company to focus on high-growth industries to drive revenue

Luna Innovations Incorporated (NASDAQ: LUNA - News) has announced a new corporate strategy to grow revenue that focuses on serving high-growth industries with new technology solutions to measure, monitor, protect and improve critical processes in the medical, defense and composites industries.

The strategy, recently approved by the company’s Board of Directors, focuses on three key objectives:

    Become the leading provider of sensing systems and standard test methods for composite materials by offering disruptive technology that revolutionizes the industry.

Published: 15 December 2011
Written by Editor
Nasdaq   Healthcare   Up on News   Interesting News  
Read more: Luna Innovations Incorporated ( LUNA )

TranS1 Inc. Announces Reimbursement Coverage Decision Regarding AxiaLIF(R) Procedure

TranS1 Inc. (Nasdaq:TSON - News), a pioneer in minimally invasive approaches to lumbar spine surgery, today announced that Palmetto GBA ("Palmetto"), a Medicare Administrative Contractor, has removed its Non-Coverage policy for AxiaLIF effective January 1, 2012.

In its letter, Palmetto indicated that its medical directors had reviewed the AxiaLIF clinical information and decided "...the benefits are well supported by high-quality evidence, and has clinical value." Palmetto provides care to approximately nine million Medicare beneficiaries in California, Virginia, North Carolina, South Carolina, Nevada, West Virginia and Hawaii.

Published: 14 December 2011
Written by Editor
Nasdaq   Healthcare   Project Updates   Up on News   Interesting News  
Read more: TranS1 Inc ( TSON )
  1. Synovis Life Technologies Inc ( SYNO )
  2. China Medical Technologies Inc ( CMED )
  3. FONAR Corporation ( FONR )
  4. Align Technology Inc ( ALGN )
  5. Zeltiq Aesthetics Inc ( ZLTQ )